RISK-BENEFIT ANALYSIS AND CASE-STUDY ON TRIBUTYL TIN

被引:3
|
作者
MOORE, L
POSTLE, M
机构
[1] Risk and Policy Analysts Limited (RPA), Loddon, Norfolk NR14 6JL, Warren House, Beccles Road
关键词
D O I
10.1016/0964-8305(94)90097-3
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The Risk-Benefit Analysis (RBA) methodology was developed for the Department of the Environment to assist in the evaluation of regulatory choices concerning hazardous chemicals. RBA considers the risks (human and environmental) and benefits (direct and indirect) associated with the use of a hazardous substance and aims to express these in monetary terms. Through detailed consideration of the existing regulatory regime and the effects of possible regulatory changes, RBA highlights (and quantifies) the trade-offs which would be involved. The tributyl tin (TBT) case study considered the use of TBT in antifouling paints. Through the application of the RBA methodology it looked at the impact (in the UK and the EC) of a ban on the use of TBT and of stricter controls at docks involved in the repainting of ships. Valuation of the economic benefits associated with the use of TBT enabled the risks associated with its use to be implicity valued.
引用
收藏
页码:401 / 412
页数:12
相关论文
共 50 条
  • [21] BRAFO -: Risk-benefit analysis of foods
    Boobis, Alan
    Contor, Laura
    Kind, Paul
    Mueller, Detlef
    Rechkemmer, Gerhard
    Verhagen, Hans
    Szoradi, Andras
    [J]. ANNALS OF NUTRITION AND METABOLISM, 2007, 51 : 393 - 394
  • [22] Losing the balance in risk-benefit analysis
    Rehani, Madan M.
    [J]. JOURNAL OF RADIOLOGICAL PROTECTION, 2023, 43 (02)
  • [23] THE ILEOANAL POUCH - A RISK-BENEFIT ANALYSIS
    KOHLER, L
    TROIDL, H
    [J]. BRITISH JOURNAL OF SURGERY, 1995, 82 (04) : 443 - 447
  • [24] Labour analgesia - A risk-benefit analysis
    Eberle, RL
    Norris, MC
    [J]. DRUG SAFETY, 1996, 14 (04) : 239 - 251
  • [25] ADVICE AND CONSENT + RISK-BENEFIT ANALYSIS
    BONINE, JE
    [J]. ATLANTIC, 1979, 243 (05): : 31 - 31
  • [26] Hormones and cancer: Risk-benefit analysis
    Sevelda, P
    Salzer, H
    [J]. GYNAKOLOGISCH-GEBURTSHILFLICHE RUNDSCHAU, 1998, 38 (02): : 61 - 63
  • [27] Quantitative risk-benefit analysis of natalizumab
    Thompson, J. P.
    Noyes, K.
    Dorsey, E. R.
    Schwid, S. R.
    Holloway, R. G.
    [J]. NEUROLOGY, 2008, 71 (05) : 357 - 364
  • [28] Basic aspects of risk-benefit analysis
    Beckmann, J
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1999, 25 (01): : 89 - 95
  • [29] Risk-benefit analysis of fish consumption
    Leblanc, Jean-Charles
    Sirot, Veronique
    Volatier, Jean-Luc
    [J]. CAHIERS DE NUTRITION ET DE DIETETIQUE, 2009, 44 (04): : 182 - 188
  • [30] A RISK-BENEFIT ANALYSIS FOR THE TREATMENT OF HYPERTENSION
    BULPITT, CJ
    [J]. POSTGRADUATE MEDICAL JOURNAL, 1993, 69 (816) : 764 - 774